Skip to main content

Advertisement

Table 4 Multivariate analysis: risk factors associated with VRE acquisition

From: Hospital acquired vancomycin resistant enterococci in surgical intensive care patients – a prospective longitudinal study

Risk factors (p ≤ 0.05) Odds Ratio 95% CI
Duration of stay 0.90 0.84–0.96
Long-term-dialysis 0.08 0.01–1.10
Flucloxacillin treatment 0.09 0.01–0.60
Piperacillin/tazobactam treatment 0.24 0.05–1.13